OverviewSuggest Edit

Biodesy has developed a unique and highly sensitive means of detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called ‘second-harmonic generation’ (SHG), can monitor structural change at any site within a protein, in real time.

TypePrivate
Founded2013
HQSouth San Francisco, US
Websitebiodesy.com

Recent NewsAll News

Latest Updates

Employees (est.) (Jan 2020)26(-3%)

Key People/Management at Biodesy

Ariel Notcovich

Ariel Notcovich

CEO
Lou Dietz

Lou Dietz

Vice President of Engineering
Show more

Biodesy Office Locations

Biodesy has an office in South San Francisco
South San Francisco, US (HQ)
170 Harbor Way #100
Show all (1)

Biodesy Financials and Metrics

Summary Metrics

Founding Date

2013

Biodesy total Funding

$45.4 m

Biodesy latest funding size

$20 m

Time since last funding

a year ago

Biodesy investors

Biodesy's latest funding round in September 2018 was reported to be $20 m. In total, Biodesy has raised $45.4 m
Show all financial metrics

Biodesy Online and Social Media Presence

Embed Graph

Biodesy Blogs

JOSHUA SALAFSKY, PhD

Josh is the Founder of Biodesy and the inventor of the Second Harmonic Generation (SHG) technique for studying biological molecules. Josh was awarded a number of NSF and NIH grants and obtained key scientific breakthroughs that galvanized the scientific and venture capital communities.  Previously, …

Mark Gallop, PhD

Mark Gallop joined 5AM Ventures as an Executive-in-Residence in June 2018, and consults with emerging biotechnology companies on drug discovery technologies and strategies, with an emphasis on neuroscience, oncology, gastrointestinal disorders and prodrug design. From 2012 to 2017 he served as the f…

Mitchell Mutz, PhD

Mitchell Mutz, PhD, is an  Investment Director at the Roche Venture Fund.  He joined Roche in 2017, bringing a broad depth of experience as founder, President, and Chief Scientific Officer of Amplyx Pharmaceuticals, a clinical stage therapeutics company that is currently developing APX001, a novel, …

Ariel Notcovich

Ariel G. Notcovich is an accomplished life science executive, with a wide experience in all aspects and stages of product development for life science markets, having worked in startup as well as in corporate environments. Ariel founded ProteOptics during his graduate studies in Physics at the Techn…

Research Associate I/II/Sr. Research Associate – Assay Development

Biodesy is a well-funded startup, commercializing the first services and systems to rapidly measure structural changes of biological molecules in high-throughput. Biodesy has developed a unique and highly sensitive technology for detecting these changes in real time. Our products enable screening fo…

Scientist – Assay Development

Biodesy is a well-funded startup, commercializing the first services and systems to rapidly measure structural changes of biological molecules in high-throughput. Biodesy has developed a unique and highly sensitive technology for detecting these changes in real time. Our products enable screening fo…
Show more

Biodesy Frequently Asked Questions

  • When was Biodesy founded?

    Biodesy was founded in 2013.

  • Who are Biodesy key executives?

    Biodesy's key executives are Ariel Notcovich and Lou Dietz.

  • How many employees does Biodesy have?

    Biodesy has 26 employees.

  • Who are Biodesy competitors?

    Competitors of Biodesy include OxThera, Affinivax and Castle Biosciences.

  • Where is Biodesy headquarters?

    Biodesy headquarters is located at 170 Harbor Way #100, South San Francisco.

  • Where are Biodesy offices?

    Biodesy has an office in South San Francisco.

  • How many offices does Biodesy have?

    Biodesy has 1 office.